Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
- PMID: 26942001
- PMCID: PMC4749796
- DOI: 10.1155/2016/5431021
Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
Abstract
Purpose. Pterygium is a serious eye problem in countries with high exposure to UV. However, despite numerous studies, the molecular etiology of pterygium is unclear. Recent studies have indicated that LATS1 and LATS2 genes are involved in DDR signaling pathways against continuous UV exposure. Our aim was to evaluate the LATS1 and LATS2 promoter methylation with the risk of pterygium formation. Methods. We evaluated the promoter methylation status of LATS1 and LATS2 using methylation-specific PCR technique. Also, mRNA expression of LATS1 and LATS2 was assessed in 14 cases of pterygium and 14 normal specimens by real-time PCR. Results. Promoter methylation of LATS1 and LATS2 was detected significantly between pterygium tissues and normal tissues [LATS1; OR = 4.9; 95% CI: 1.54 to 15.48, P = 0.003; LATS2; OR = 7.1; 95% CI: 1.53 to 33.19, P = 0.004]. The gene expression analysis showed a statistically significant difference between pterygium tissues and healthy controls for both LATS1 and LATS2 (P < 0.05). Conclusions. The data of this study is the first report regarding the effect of promoter methylation of the LATS1 and LATS2 in the pterygium. To confirm these data, doing further studies in various genetic populations with large sample sizes using advanced molecular techniques is proposed.
Figures
Similar articles
-
Contribution of LATS1 and LATS2 promoter methylation in OSCC development.J Cell Commun Signal. 2017 Mar;11(1):49-55. doi: 10.1007/s12079-016-0356-4. Epub 2016 Oct 19. J Cell Commun Signal. 2017. PMID: 27761802 Free PMC article.
-
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.Clin Cancer Res. 2005 Feb 15;11(4):1380-5. doi: 10.1158/1078-0432.CCR-04-1773. Clin Cancer Res. 2005. PMID: 15746036
-
Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.Neurosci Res. 2006 Dec;56(4):450-8. doi: 10.1016/j.neures.2006.09.006. Epub 2006 Oct 17. Neurosci Res. 2006. PMID: 17049657
-
Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.Pathol Oncol Res. 2018 Apr;24(2):207-214. doi: 10.1007/s12253-017-0225-3. Epub 2017 Apr 22. Pathol Oncol Res. 2018. PMID: 28434174
-
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.Cell Death Differ. 2017 Sep;24(9):1488-1501. doi: 10.1038/cdd.2017.99. Epub 2017 Jun 23. Cell Death Differ. 2017. PMID: 28644436 Free PMC article. Review.
Cited by
-
Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.Asian Pac J Cancer Prev. 2020 May 1;21(5):1283-1287. doi: 10.31557/APJCP.2020.21.5.1283. Asian Pac J Cancer Prev. 2020. PMID: 32458634 Free PMC article.
-
Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.Asian Pac J Cancer Prev. 2021 Mar 1;22(3):977-982. doi: 10.31557/APJCP.2021.22.3.977. Asian Pac J Cancer Prev. 2021. PMID: 33773564 Free PMC article.
-
Identification and differentiation therapy strategy of pterygium in vitro.Am J Transl Res. 2018 Aug 15;10(8):2619-2627. eCollection 2018. Am J Transl Res. 2018. PMID: 30210698 Free PMC article.
-
LATS1 inhibits metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.Int J Clin Exp Pathol. 2018 Apr 1;11(4):2053-2063. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938312 Free PMC article.
-
Contribution of LATS1 and LATS2 promoter methylation in OSCC development.J Cell Commun Signal. 2017 Mar;11(1):49-55. doi: 10.1007/s12079-016-0356-4. Epub 2016 Oct 19. J Cell Commun Signal. 2017. PMID: 27761802 Free PMC article.
References
-
- Akhter W., Tayyab A., Kausar A., Masrur A. Reducing postoperative pterygium recurrence: comparison of free conjunctival auto-graft and conjunctival rotation flap techniques. Journal of the College of Physicians and Surgeons Pakistan. 2014;24(10):740–744. - PubMed
-
- Takahashi Y., Miyoshi Y., Takahata C., et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clinical Cancer Research. 2005;11(4):1380–1385. doi: 10.1158/1078-0432.CCR-04-1773. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources